Thromb Haemost 1996; 75(02): 254-257
DOI: 10.1055/s-0038-1650255
Original Article
Schattauer GmbH Stuttgart

The Effects of Long-term Heparin Therapy During Pregnancy on Bone Density

A Prospective Matched Cohort Study
James D Douketis
1   The Department of Medicine, Chedoke-McMaster Hospitals and McMaster University, Hamilton, Ontario, Canada
,
Jeffrey S Ginsberg
1   The Department of Medicine, Chedoke-McMaster Hospitals and McMaster University, Hamilton, Ontario, Canada
,
Robert F Burrows
2   The Departments of Obstetrics and Gynecology, Chedoke-McMaster Hospitals and McMaster University, Hamilton, Ontario, Canada
,
Eric K Duku
3   The Departments of Clinical Epidemiology and Biostatistics, Chedoke-McMaster Hospitals and McMaster University, Hamilton, Ontario, Canada
,
Colin E Webber
4   The Department of Nuclear Medicine, Chedoke-McMaster Hospitals and McMaster University, Hamilton, Ontario, Canada
,
Patrick Brill-Edwards
1   The Department of Medicine, Chedoke-McMaster Hospitals and McMaster University, Hamilton, Ontario, Canada
› Author Affiliations
Further Information

Publication History

Received: 29 April 1995

Accepted after resubmission20 October 1995

Publication Date:
26 July 2018 (online)

Summary

We performed a prospective matched cohort study to investigate the effects of long-term (>1 month) heparin therapy on lumbar spine bone density. Twenty-five women who received heparin during pregnancy, and 25 matched controls underwent dual photon absorptiometry of the lumbar spine in the post-partum period. Zero of 25 heparin-treated patients developed fractures. Heparin-treated patients had a 0.082 g/cm2 lower bone density compared to untreated controls, which is clinically and statistically significant (p = 0.0077). There were 6 matched pairs in which only the heparin-treated patient had a bone density below 1.0 g/ cm2, compared to only one pair in which only the control patient had a bone density below this level (p = 0.089). The correlation coefficients of the difference .in bone density in each matched pair, and the duration of heparin therapy, the mean daily dose, and the total dose of heparin were 0.042, -0.015, and 0.021, respectively; none of these values is statistically significant. We conclude: 1) long-term heparin therapy was associated with a significant reduction in bone density, although fractures are uncommon, 2) there was no significant correlation between lumbar bone density and the dose or duration of heparin.

 
  • References

  • 1 Ginsberg JS, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 1992; 102: 385s-390s
  • 2 Ginsberg JS, Hirsh J, Turner C, Burrows R, Levine MN. Risks to the fetus of anticoagulant therapy during pregnancy. Thromb Haemost 1989; 149: 2233-2236
  • 3 Levine MN. Non-hemorrhagic complications of anticoagulant therapy. Semin Thromb Haemost 1986; 12: 63-66
  • 4 Griffith GC, Nichols Jr G, Asher JD, Flanagan B. Heparin osteoporosis. JAMA 1965; 193: 91-94
  • 5 Dahlman TC. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993; 168: 1265-1270
  • 6 Hellgren M, Nygards E-B. Long-term therapy with subcutaneous heparin during pregnancy. Gynecol Obstet Invest 1982; 13: 76-89
  • 7 Dahlman T, Lindvall N, Hellgren M. Osteopenia in pregnancy during long-term heparin treatment: A radiological study post partum. Br J Obstet Gynecol 1990; 97: 221-228
  • 8 Johnston Jr CC, Epstein S. Clinical, biochemical, radiographic, epidemiology, and economic features of osteoporosis. Ortho Clin North Am 1981; 12: 559-569
  • 9 Smith DM, Khairi MRA, Johnston Jr CC. The loss of bone mineral and its relationship to the risk of fracture. J Clin Invest 1975; 56: 311-318
  • 10 Hiu SL, Slemenda CS, Jonston Jr CC. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 1988; 81: 1804-1809
  • 11 Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Scott JC, Vogt TM. Bone density at various sites for prediction of hip fractures. Lancet 1993; 341: 72-75
  • 12 Wasnich RD, Ross PD, Heillbrun LK, Vogel JM. Selection of the optimal site for fracture site prediction. Clin Orthop 1987; 81: 262-268
  • 13 Briney WG. Is measurement of bone density useful. Rheum Dis Clin North Am 1993; 19: 95-106
  • 14 Heuck AF, Block J, Glueer C-C, Steiger P, Genant HK. Mild versus definite osteoporosis: Comparison of bone densitometry techniques using different statistical models. J Bone Min Res 1989; 4: 891-900
  • 15 Barbour LA, Kick SD, Steiner JF, LoVerde ME, Heddleston LN, Lear JL, Baron AE, Barton PL. A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry. Am J Obstet Gynecol 1994; 170: 862-869
  • 16 Dahlman TC, Sjoberg HE, Ringertz H. Bone mineral density during longterm prophylaxis with heparin in pregnancy. Am J Obstet Gynecol 1994; 170: 1315-1320
  • 17 Jaffe MD, Willis PW III. Multiple fractures associated with long-term sodium heparin therapy. JAMA 1965; 193: 158-160
  • 18 Silber M, Olund A. Successful outcome of pregnancy complicated by giant myoma and severe heparin-induced osteopenia. Gynecol Obstet Invest 1989; 28: 51-52
  • 19 Squires JW, Pinch LW. Heparin-induced spinal fractures. JAMA 1979; 241: 2417-2418
  • 20 Sackler JP, Liu L. Heparin-induced osteoporosis. Br J Radiol 1973; 46: 548-550
  • 21 Griffiths HT, Liu DTY. Severe heparin osteoporosis in pregnancy. Postgrad Med J 1984; 60: 424-425
  • 22 Wise PH, Hall AJ. Heparin-induced osteoporosis in pregnancy. Br Med J 1980; 2: 110-111
  • 23 De Swiet M, Ward PD, Fidler J, Horsman A, Katz D, Letsky E, Peacock M, Wise PH. Prolonged heparin therapy in pregnancy causes bone demineralization. Br J Obstet Gynecol 1983; 90: 1129-1134
  • 24 Ginsberg JS, Kowalchuk G, Hirsh J, Brill-Edwards P, Burrows R, Coates G, Webber C. Heparin effect on bone density. Thromb Haemost 1990; 64: 286-289
  • 25 Melton LJ III, Eddy DM, Johnston Jr CC. Screening for osteoporosis. Ann Intern Med 1990; 112: 516-528
  • 26 Pocock N, Eisman J, Gwinn T, Sambrook P, Kelly P, Freund J, Yeates M. Muscle strength, physical fitness, and weight but not age predict femoral neck bone mass. J Bone Min Res 1989; 4: 441-446
  • 27 Pocock NA, Eisman JA, Yeates MG, Sambrook PN, Eberl S. Physical fitness is a major determinant of femoral neck and lumbar spine bone mineral density. J Clin Invest 1986; 78: 618-621
  • 28 Stevenson JC, Lees B, Devenport M, Cust MP, Ganger KF. Determinants of bone density in normal women: risk factors for future osteoporosis. Br Med J 1989; 298: 924-928
  • 29 Hopper JL, Seeman E. The bone density of female twins discordant for tobacco use. N Engl J Med 1994; 330: 387-392
  • 30 Webber CE. Some factors which influence the evaluation of a dual photon measurement of lumbar spine bone mineral mass. J Can Radiol Assoc 1989; 40: 87-91
  • 31 Matzsch T, Bergqvist D, Hedner U, Nilsson B, Ostergaard P. Heparin-induced osteoporosis in rats. Thromb Haemost 1986; 56: 293-294
  • 32 Monreal M, Vinas L, Monreal L, Lavin S, Lafoz E, Angles AM. Heparin-related osteoporosis in rats. A comparative study between unfractionated heparin and a low molecular weight heparin. Haemostasis 1990; 20: 204-207
  • 33 Matzsch T, Bergqvist D, Hedner U, Nilsson B, Ostergaard P. Effects of low molecular weight heparin and unfractionated heparin on induction of osteoporosis in rats. Thromb Haemost 1990; 65: 505-509
  • 34 Riggs BL, Wahner HW, Dunn WL, Mazess RB, Offord KP, Melton LJ III. Differential changes in bone density of the appendicular and axial skeleton with ageing: relationship to spinal osteoporosis. J Clin Invest 1981; 67: 328-335
  • 35 Melton LJ, Wahner HW, Richelson LS, O’Fallon WM, Riggs BL. Osteoporosis and the risks of hip fracture. Am J Epidemiol 1986; 124: 254-261
  • 36 Gardner SB, Winter PD, Gardner MJ. Confidence Interval Analysis, British Medical Journal. copyright 1991, version 1.1
  • 37 Christiansen C, Riis BJ. Five years with continuous combined estrogen progesterone therapy. Br J Obstet Gynecol 1990; 97: 1087-1092
  • 38 Riggs BL, Melton LJ III. Involutional osteoporosis. N Engl J Med 1986; 314: 1676-1686
  • 39 Chan GM, Slater P, Roberts CC, Thomas MR, Folland D, Jackson R. Bone mineral status of lactating mothers of different ages. Am J Obstet Gynecol 1982; 144: 438-441
  • 40 Hayslip CC, Klein TA, Wray HL, Duncan WE. The effect of lactation on bone mineral content in healthy postpartum women. Obstet Gynecol 1989; 73: 588-592
  • 41 Anonymous. Extended lactation and loss of bone. Nutr Rev 1994 52. 25-28
  • 42 Sowers M, Corton G, Shapiro B, Jannausch ML, Crutchfield M, Smith ML, Randolph JF, Hollis B. Changes in bone density with lactation. JAMA 1993; 269: 3130-3135
  • 43 Omri A, Delaloye JF, Bachmann F. Low molecular weight heparin novo (LHN-1) does not cross the placenta during the second trimester of pregnancy. Thromb Haemost 1989; 61: 55-56
  • 44 Monreal M, Olive A, Lafoz E, del Rrio L. Heparins, coumarin, and bone density. Lancet 1991; 338: 706
  • 45 Melissari E, Murray WJG, Das S, Wilson NV, Philip M, Kakkar VV. Does low molecular weight heparin have a role in the development of osteoporosis. Thromb Haemost 1993; 69: 646